Edition:
United States

People: Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

66.92USD
10:53am EST
Change (% chg)

$-0.88 (-1.30%)
Prev Close
$67.80
Open
$67.23
Day's High
$67.26
Day's Low
$66.57
Volume
271,598
Avg. Vol
1,284,074
52-wk High
$88.16
52-wk Low
$64.25

Prendergast, Franklyn 

Dr. Franklyn G. Prendergast, M.D., Ph.D., is Independent Director of Eli Lilly & Co. Dr. Prendergast is a prominent medical clinician, researcher, and academician. He has extensive experience in senior-most administration at Mayo Clinic, a major medical institution, and as director of its renowned cancer center. He retired from Mayo at the end of 2014. He has special expertise in two critical areas for Lilly—oncology and personalized medicine. As a medical doctor, he brings an important practicing-physician perspective to the Board’s deliberations.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Lechleiter

16,562,500

Derica Rice

6,935,410

Maria Crowe

--

Jan Lundberg

6,778,350

Melissa Barnes

--

Michael Harrington

4,780,500
As Of  30 Dec 2015